Tower Research Capital »

Avalo Therapeutics Ord shares owned by Tower Research Capital

Quarter-by-quarter ownership of Avalo Therapeutics Ord (AVTX) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Avalo Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Avalo Therapeutics Ord held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalo Therapeutics Ord by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $329 26 12.69
2024-12-31 $31k 4.1k 7.43
2024-09-30 $3.6k 376 9.50
2024-03-31 $36k 1.6k 21.75

More positions owned by Tower Research Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Direxion Shs Etf Tr Dly Scond 3xbu (SOXL)
Alphabet Cap Stk Cl A (GOOGL)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Vanguard Instl Index 0-3 Mo Treas Bil (VBIL)
Ishares Tr Rus 1000 Etf (IWB)
Ishares Tr 0-3 Mnth Treasry (SGOV)

View all positions for Tower Research Capital

Top funds holding Avalo Therapeutics Ord

BVF
OrbiMed Advisors
Nantahala Capital Management
Point72 Asset Management
Affinity Asset Advisors
Caligan Partners
Balyasny Asset Management
Silverarc Capital Management
Vanguard Group
RA Capital Management
Citadel Advisors
TCG Crossover Management
Commodore Capital
Velan Capital Investment Management
Adage Capital Partners GP

View all funds holding Avalo Therapeutics Ord